Dec 16 (Reuters) - Inventiva SA IVAA.PA :
* SECURES €21.4 MILLION AND COMPLETES THE FIRST TRANCHE OF
THE
PREVIOUSLY ANNOUNCED MULTI-TRANCHE FINANCING OF UP TO €348
MILLION
* ADDITIONAL CASH REQUIREMENTS ESTIMATED AT €120 MILLION TO
€130
MILLION
* PROCEEDS TO ADVANCE PHASE III NATIV3 CLINICAL TRIAL
* APPOINTS MARK PRUZANSKI AS CHAIRMAN AND SRINIVAS AKKARAJU
TO
BOARD
* COMPANY ESTIMATES FINANCING OPERATIONS UNTIL MID-Q3 2025
* NET PROCEEDS OF €20.1 MILLION TO FUND CLINICAL PROGRAM AND
CORPORATE PURPOSES
* BOARD APPROVES SECOND PHASE OF TRANCHE 1 FOR €21.4 MILLION
Source text: nGNEb8mzKM
Further company coverage: IVAA.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))